Giant Uterus Heads for GOP Convention!!

[Star]

OMG? --- so to speak


Giant Uterus Heads for GOP Convention!! - Blogs - Forums

 

[Avatar4321]

Thats really no way to talk about the Vice President of the United States. I know Biden is goofy and ridiculous, but the office still requires some respect.

 

[LordBrownTrout]

Will O have NO abort?

 

[Star]

OMG? --- so to speak


Giant Uterus Heads for GOP Convention!! - Blogs - Forums

If Isaac's a "legitimate" storm, they won't need an, um, er, uh umbrella.

 

[buckeye45_73]

is it the democrats time of the month again, you guys are nothing but bloody vaginas or pussys....whatever you want to call yourself

 

[oreo]

Thats really no way to talk about the Vice President of the United States. I know Biden is goofy and ridiculous, but the office still requires some respect.

Good One--I imagine the DNC is real happy that Joe Biden cancelled his trip to Tampa.

 

[Avatar4321]

BTW you guys do realize that the hurricane isnt going anywhere near the convention, right?

 

[uscitizen]

So Bush is going to the convention after all?
Ohh wait you said uterus, wrong hole, sorry.

 

[waltky]

Womb with a view...

Swedish doctors claim pioneering uterus transplant
Sep 18,`12 -- Two Swedish women are hoping to get pregnant after undergoing what doctors are calling the world's first mother-to-daughter uterus transplants.

Specialists at the University of Goteborg said they performed the surgery over the weekend without complications but added that they won't consider it successful unless the women give birth to healthy children. "That's the best proof," said Michael Olausson, one of the surgeons. One of the unidentified women had her uterus removed many years ago because of cervical cancer, while the other was born without a womb. Both are in their 30s. They will undergo a year of observation before doctors attempt to help them get pregnant via in vitro fertilization, in which embryos created with eggs from their own ovaries will be implanted in their wombs.

Researchers around the world have been looking for ways to transplant wombs so that women who have lost a uterus to cancer or other diseases can become pregnant. Fertility experts hailed the Swedish transplants as a significant step but stressed it remains to be seen whether they will result in successful pregnancies. Even if the approach works, it is unclear how many women will choose such an option, given the risks and the extreme nature of the operation compared with, say, using a surrogate mother. Turkish doctors last year said they performed the first successful uterus transplant, giving a womb from a deceased donor to a young woman. Olausson said that woman is doing fine, but he wasn't sure whether she has started fertility treatment.

In 2000, doctors in Saudi Arabia transplanted a uterus from a live donor, but it had to be removed three months later because of a blood clot. Olausson said there could be a lower risk of organ rejection when the donor is a family member, but he said a more important factor is the "emotional connection" between mother and daughter. Also, the mother-daughter procedure makes it easier to "know that the transplanted organ works," he said, adding that it doesn't matter whether the donor is past menopause. For a year, doctors will monitor how the two patients respond to the anti-rejection drugs needed to stop their immune systems from attacking the donated wombs.

After a maximum of two pregnancies, the wombs will be removed so the women can stop taking the drugs, which can have side effects such as high blood pressure, swelling and diabetes and may also raise the risk of some types of cancer. "There's no doubt this will be a pioneering step if it's been successful," said Scott Nelson, chairman of obstetrics and gynecology at the University of Glasgow, Scotland. "At present, the only option for these women is to have a surrogacy - i.e., having their embryos implanted into another woman." Nelson said a donated womb would not contain all the blood vessels it originally had, possibly compromising a baby's development. "Pre-term birth is a major risk - i.e., a small baby being born. That's what you'd mainly be worried about," he said.

MORE

See also:

Mother-to-daughter womb transplant 'success' in Sweden
18 September 2012: Doctors say the operations will only be considered a complete success if they result in children

Two Swedish women could be able to give birth using the wombs in which they were carried, doctors say, hailing the world's first mother-to-daughter uterus transplants. The weekend procedures were completed by more than 10 surgeons at Sweden's University of Gothenburg. The names of the patients have not been revealed.

Doctors caution they will not consider the operations successful unless the women achieve pregnancy. "We are not going to call it a complete success until this results in children," said Michael Olausson, one of the Swedish surgeons told The Associated Press. "That's the best proof." Both women started in-vitro fertilisation before the surgery, he said, adding that their frozen embryos will be thawed and transferred if the women are considered in good enough health after a year-long observation period.

Up and walking

Both recipients, who are aged in their 30s, were tired after the surgery but recovering well, said the university in a statement. One had her uterus removed due to cervical cancer and the other was born without a uterus, they added. "The donating mothers are up and walking and will be discharged from the hospital within a few days," said Mats Brannstrom, a professor of obstetrics and gynaecology at the university. He is the leader of a research team - comprising 20 scientists, doctors and specialists - which has been working on the project since 1999.

Turkish doctors said they had performed a successful uterus transplant last year, giving a womb from a deceased donor to a young woman, but Dr Olausson said he was not sure whether the recipient had yet started undergoing fertility treatment. The first widely reported womb transplant from a live donor was performed in 2000, in Saudi Arabia, but the organ had to be removed three months later because of a blood clot. Last year, 56-year-old Eva Ottoson, who lives in Nottinghamshire, said she hoped to become the first woman to have her womb transplanted into her daughter, Sara, 25, who lives in Sweden and was born without reproductive organs. It remains unknown whether they were involved in the weekend's procedures.

BBC News - Mother-to-daughter womb transplant 'success' in Sweden

 

[waltky]

New cervical cancer vaccine...

Researchers Develop Vaccine to Treat Cervical Cancer
October 10, 2012 - Researchers have developed an experimental vaccine to treat cervical cancer, the leading cause of cancer death among women worldwide.

The World Health Organization estimates that about 500,000 new cases of cervical cancer are diagnosed each year, mostly among women in the poorest regions of the world - sub-Saharan Africa, Latin America and parts of Asia. The disease kills about 274,000 women every year. Most cervical cancers are caused by infection with the human papilloma virus, or HPV. Two varieties of the sexually-transmitted disease, known as HPV types 16 and 18, cause up to 75 percent of all cervical cancers. A vaccine already exists to prevent the acquisition and spread of HPV 16 and 18, as well as other strains of HPV that cause genital warts. The new, experimental drug is designed to treat women who already are infected with HPV and who are at risk of developing cervical cancer.

Niranjan Sardesai is chief of research and development for Inovio Pharmaceuticals, a Pennsylvania company developing the therapeutic vaccine. “Globally, you know, there is a large unmet need in terms of large numbers of women and men who go unvaccinated. So the disease burden is there. And our vaccine, if successful, has the potential to address large populations that are HPV-infected," said Sardesai. Unlike other vaccines that stimulate an immune response by exposing the body to a bacterial or viral protein, the cervical cancer treatment is what is called a DNA vaccine.

Researchers make the vaccine using small bits of viral DNA that code for a specific protein. Once injected, these DNA fragments direct the patient’s cells to produce copies of the infectious protein, or antigen, that stimulate a strong immune response against HPV-infected cells. Again, chemist Niranjan Sardesai: “So our approach works exactly like vaccines do, which is you immunize people with the target protein or the target antigen, have your body produce immune responses against the target antigen, with one major difference - we are asking the body to produce the target antigen on its own to which it can then produce an immune response," said Sardesai.

In a safety and effectiveness trial, the treatment stimulated a strong T-cell immune response in a small number of HPV-infected women. The next step, according to Sardesai, is to conduct a study to see whether the vaccine eliminates HPV infection in a larger group of patients. Sardesai says the vaccine could potentially treat several cancers stemming from human papilloma virus, including head and neck cancer, vulvar cancer in women, penile and anal cancers, and cancer of the urogenital tract. An article describing development of the HPV treatment vaccine is published in the journal Science Translational Medicine.

Source

 

[LordBrownTrout]

New cervical cancer vaccine...

Researchers Develop Vaccine to Treat Cervical Cancer
October 10, 2012 - Researchers have developed an experimental vaccine to treat cervical cancer, the leading cause of cancer death among women worldwide.

The World Health Organization estimates that about 500,000 new cases of cervical cancer are diagnosed each year, mostly among women in the poorest regions of the world - sub-Saharan Africa, Latin America and parts of Asia. The disease kills about 274,000 women every year. Most cervical cancers are caused by infection with the human papilloma virus, or HPV. Two varieties of the sexually-transmitted disease, known as HPV types 16 and 18, cause up to 75 percent of all cervical cancers. A vaccine already exists to prevent the acquisition and spread of HPV 16 and 18, as well as other strains of HPV that cause genital warts. The new, experimental drug is designed to treat women who already are infected with HPV and who are at risk of developing cervical cancer.

Niranjan Sardesai is chief of research and development for Inovio Pharmaceuticals, a Pennsylvania company developing the therapeutic vaccine. “Globally, you know, there is a large unmet need in terms of large numbers of women and men who go unvaccinated. So the disease burden is there. And our vaccine, if successful, has the potential to address large populations that are HPV-infected," said Sardesai. Unlike other vaccines that stimulate an immune response by exposing the body to a bacterial or viral protein, the cervical cancer treatment is what is called a DNA vaccine.

Researchers make the vaccine using small bits of viral DNA that code for a specific protein. Once injected, these DNA fragments direct the patient’s cells to produce copies of the infectious protein, or antigen, that stimulate a strong immune response against HPV-infected cells. Again, chemist Niranjan Sardesai: “So our approach works exactly like vaccines do, which is you immunize people with the target protein or the target antigen, have your body produce immune responses against the target antigen, with one major difference - we are asking the body to produce the target antigen on its own to which it can then produce an immune response," said Sardesai.

In a safety and effectiveness trial, the treatment stimulated a strong T-cell immune response in a small number of HPV-infected women. The next step, according to Sardesai, is to conduct a study to see whether the vaccine eliminates HPV infection in a larger group of patients. Sardesai says the vaccine could potentially treat several cancers stemming from human papilloma virus, including head and neck cancer, vulvar cancer in women, penile and anal cancers, and cancer of the urogenital tract. An article describing development of the HPV treatment vaccine is published in the journal Science Translational Medicine.

Source

Off topic. UK got the Harrison twins.